These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2863651)

  • 1. New labelled ligand for in-vivo studies of opioid physiology.
    Jones AK; Luthra SK; Pike VW; Herold S; Brady F
    Lancet; 1985 Sep; 2(8456):665-6. PubMed ID: 2863651
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers.
    Jones AK; Luthra SK; Maziere B; Pike VW; Loc'h C; Crouzel C; Syrota A; Jones T
    J Neurosci Methods; 1988 Mar; 23(2):121-9. PubMed ID: 2833666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radioiodinated 7alpha-O-iodoallyl diprenorphine for mapping opioid receptors.
    Wang RF; Tafani JA; Zajac JM; Guiraud R
    Neuropeptides; 1999 Dec; 33(6):498-502. PubMed ID: 10657531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of three structurally related ¹⁸F-labeled orvinols of different intrinsic activities: 6-O-[¹⁸F]fluoroethyl-diprenorphine ([¹⁸F]FDPN), 6-O-[¹⁸F]fluoroethyl-buprenorphine ([¹⁸F]FBPN), and 6-O-[¹⁸F]fluoroethyl-phenethyl-orvinol ([¹⁸F]FPEO).
    Schoultz BW; Hjørnevik T; Reed BJ; Marton J; Coello CS; Willoch F; Henriksen G
    J Med Chem; 2014 Jun; 57(12):5464-9. PubMed ID: 24933507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel opiate binding sites selective for benzomorphan drugs.
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography.
    Frost JJ; Mayberg HS; Sadzot B; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Links JM
    J Cereb Blood Flow Metab; 1990 Jul; 10(4):484-92. PubMed ID: 2161414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic localization of 3H-diprenorphine in the Syrian hamster.
    Gusterson BA; Neville AM; Baker JR; Christian RA
    Diagn Histopathol; 1981; 4(2):209-13. PubMed ID: 6266791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study.
    Burn DJ; Rinne JO; Quinn NP; Lees AJ; Marsden CD; Brooks DJ
    Brain; 1995 Aug; 118 ( Pt 4)():951-8. PubMed ID: 7655890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
    Richards ML; Sadée W
    J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of opioid binding sites using selective antagonists.
    Lawrence AJ; Traynor JR
    Prog Clin Biol Res; 1990; 328():121-4. PubMed ID: 1968257
    [No Abstract]   [Full Text] [Related]  

  • 11. Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro.
    Cunningham VJ; Hume SP; Price GR; Ahier RG; Cremer JE; Jones AK
    J Cereb Blood Flow Metab; 1991 Jan; 11(1):1-9. PubMed ID: 1845764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of a full-agonist orvinol for PET-imaging of opioid receptors: [11C]PEO.
    Marton J; Schoultz BW; Hjørnevik T; Drzezga A; Yousefi BH; Wester HJ; Willoch F; Henriksen G
    J Med Chem; 2009 Sep; 52(18):5586-9. PubMed ID: 19694469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential brain opioid receptor availability in central and peripheral neuropathic pain.
    Maarrawi J; Peyron R; Mertens P; Costes N; Magnin M; Sindou M; Laurent B; Garcia-Larrea L
    Pain; 2007 Jan; 127(1-2):183-94. PubMed ID: 17137714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine: differential interaction with opiate receptor subtypes in vivo.
    Sadée W; Rosenbaum JS; Herz A
    J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomography.
    Sadzot B; Price JC; Mayberg HS; Douglass KH; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Feldman MA
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):204-19. PubMed ID: 1847703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down regulation of opiate receptor in rat brain after chronic etorphine treatment.
    Tao PL; Law PY
    Proc West Pharmacol Soc; 1984; 27():557-60. PubMed ID: 6093145
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of changes in opioid receptor binding in vivo during trigeminal neuralgic pain using [11C] diprenorphine and positron emission tomography.
    Jones AK; Kitchen ND; Watabe H; Cunningham VJ; Jones T; Luthra SK; Thomas DG
    J Cereb Blood Flow Metab; 1999 Jul; 19(7):803-8. PubMed ID: 10413036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure activity and receptor binding of antagonist analgesics [[proceedings].
    Lewis JW; Rance MJ
    Psychopharmacol Bull; 1981 Jan; 17(1):83-5. PubMed ID: 6262856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.